Cargando…
Effects of systemic inflammation on relapse in early breast cancer
Chronic inflammation has been a proposed mechanism of resistance to aromatase inhibitors in breast cancer. Stratifying by HER2 status, a matched case-control study from the Wellness After Breast Cancer-II cohort was performed to assess whether or not elevated serum inflammatory biomarkers (C-Reactiv...
Autores principales: | McAndrew, Nicholas P., Bottalico, Lisa, Mesaros, Clementina, Blair, Ian A., Tsao, Patricia Y., Rosado, Jennifer M., Ganguly, Tapan, Song, Sarah J., Gimotty, Phyllis A., Mao, Jun J., DeMichele, Angela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822844/ https://www.ncbi.nlm.nih.gov/pubmed/33483516 http://dx.doi.org/10.1038/s41523-020-00212-6 |
Ejemplares similares
-
Ruxolitinib and exemestane for estrogen receptor positive, aromatase inhibitor resistant advanced breast cancer
por: Makhlin, Igor, et al.
Publicado: (2022) -
Targeted Chiral Analysis of Bioactive Arachidonic Acid Metabolites Using Liquid-Chromatography-Mass Spectrometry
por: Mesaros, Clementina, et al.
Publicado: (2012) -
Mass spectrometry-based approaches to targeted quantitative proteomics in cardiovascular disease
por: Mesaros, Clementina, et al.
Publicado: (2016) -
Quantification of Serum High Mobility Group Box 1
by Liquid Chromatography/High-Resolution Mass Spectrometry: Implications
for Its Role in Immunity, Inflammation, and Cancer
por: Weng, Liwei, et al.
Publicado: (2018) -
BluePen Biomarkers LLC: integrated biomarker solutions
por: Blair, Ian A, et al.
Publicado: (2016)